When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?

الملخص EN

For patients with Relapsing Remitting Multiple Scierosis Beta Interfaerons and Glatiramer Acetate were the first to be licensed for treatment.

This review deals with one major question: when to initiate therapy? Through exploring the unique characteristics of the disease and treatement we suggest an approach that should be helpful in the process of decision-making.